Cardiovascular risk factors after Kawasaki disease: A case-control study

Silva, Anna A.E e; Maeno, Yasuki; Hashmi, Aijaz; Smallhorn, Jeffrey F.; Silverman, Earl D.; McCrindle, Brian W.

doi:10.1067/mpd.2001.111430

Cited by 73 publications

(49 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several previous reports have shown that there is systemic endothelial dysfunction late after the onset of KD, as reflected in the FMD of the brachial artery, particularly in children with CAA. 5,12,14,[19][20][21] However, other reports found that systemic endothelial dysfunction was not present late after KD 13,22 and did not find any relationship with coronary artery involvement. 20 In our small study, we found significantly decreased FMD of the brachial artery in the KD patient complicated with CAA.…”

Section: Circulation Journal Vol72 October 2008mentioning

confidence: 90%

Effects of Statin Therapy in Children Complicated With Coronary Arterial Abnormality Late After Kawasaki Disease

Huang

Weng

Chang

et al. 2008

Circ J

View full text Add to dashboard Cite

Section: Circulation Journal Vol72 October 2008mentioning

confidence: 90%

Effects of Statin Therapy in Children Complicated With Coronary Arterial Abnormality Late After Kawasaki Disease

Huang

Weng

Chang

et al. 2008

Circ J

View full text Add to dashboard Cite

“…103,[231][232][233] Furthermore, patients with Kawasaki disease seem to have a more adverse cardiovascular risk profile, with higher blood pressure and greater adiposity, as compared with control children. 234 The risk level for a given patient with coronary artery involvement may change over time because of the changes in coronary artery morphology. For example, the development of thrombosis or stenosis associated with an aneurysm increases the risk for myocardial ischemia.…”

Section: Risk Stratificationmentioning

confidence: 99%

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease

Newburger¹,

Takahashi²,

Gerber³

et al. 2004

Circulation

1,578

818

View full text Add to dashboard Cite

Background— Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop in ∼15% to 25% of untreated children and may lead to ischemic heart disease or sudden death. Methods and Results— A multidisciplinary committee of experts was convened to revise the American Heart Association recommendations for diagnosis, treatment, and long-term management of Kawasaki disease. The writing group proposes a new algorithm to aid clinicians in deciding which children with fever for ≥5 days and ≤4 classic criteria should undergo echocardiography, receive intravenous gamma globulin (IVIG) treatment, or both for Kawasaki disease. The writing group reviews the available data regarding the initial treatment for children with acute Kawasaki disease, as well for those who have persistent or recrudescent fever despite initial therapy with IVIG, including IVIG retreatment and treatment with corticosteroids, tumor necrosis factor-α antagonists, and abciximab. Long-term management of patients with Kawasaki disease is tailored to the degree of coronary involvement; recommendations regarding antiplatelet and anticoagulant therapy, physical activity, follow-up assessment, and the appropriate diagnostic procedures to evaluate cardiac disease are classified according to risk strata. Conclusions— Recommendations for the initial evaluation, treatment in the acute phase, and long-term management of patients with Kawasaki disease are intended to assist physicians in understanding the range of acceptable approaches for caring for patients with Kawasaki disease. The ultimate decisions for case management must be made by physicians in light of the particular conditions presented by individual patients.

show abstract

“…Koroner arter anevrizmalarının 2/3'ü bir yıl içerisinde ekokardiyografik olarak düzelmektedir. Dev anevrizmalar (>8mm) genellikle tromboz ve stenoza yol açarak fatal komplikasyonlara neden olmaktadır (1,6,10,11). Ağır miyokardiyal fonksiyon bozukluğuna sebep olan durumlarda koroner arter bypass greftlemesi, hatta kalp transplantasyonu yapılması gerekli olmaktadır (10).…”

Section: -------------------------------------------------Kawasaki̇ Haunclassified

Kawasaki̇ Hastaliği

Özdemir¹,

KENDİRLİ²

2004

Ankara Üniversitesi Tıp Fakültesi Mecmuası

View full text Add to dashboard Cite

Cardiovascular risk factors after Kawasaki disease: A case-control study

Cited by 73 publications

References 24 publications

Effects of Statin Therapy in Children Complicated With Coronary Arterial Abnormality Late After Kawasaki Disease

Effects of Statin Therapy in Children Complicated With Coronary Arterial Abnormality Late After Kawasaki Disease

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease

Kawasaki̇ Hastaliği

Contact Info

Product

Resources

About